NVCR NovoCure Ltd
2026Q1 · CUSIP G6674U108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
220
Δ holders QoQ
-18
Breadth percentile
Top 91%
Whale holders
114
Δ whales
-2
Inst. holding value
$1.1B
New positions
38
Closed positions
56
Price momentum (1Q)
—
Put / Call
3/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 10 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 16% | — | — |
| 2022Q2 | Top 15% | — | — |
| 2021Q2 | Top 5% | — | — |
| 2020Q4 | Top 7% | — | — |
| 2020Q3 | Top 14% | — | — |
| 2020Q1 | Top 10% | — | — |
| 2019Q3 | Top 1% | — | — |
| 2019Q1 | Top 6% | — | — |
| 2018Q3 | Top 14% | — | — |
| 2018Q2 | Top 6% | — | — |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
5
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.53
EPS YoY
—
Revenue (TTM)
$0.7B
Revenue YoY
+8.5%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)